AstraZeneca Bets Big on China with $15B Innovation Push 🌏💊
AstraZeneca announces $15B China expansion through 2030, boosting UK-China science ties as CEO Soriot highlights collaboration during PM Starmer’s visit.
AstraZeneca
Read More
AstraZeneca Bets $14.2B on China’s Innovation Boom 💊🌏
AstraZeneca announces a $14.2B investment in China, highlighting the country’s growing role in global pharmaceutical innovation. 💼🔬
AstraZeneca Bets Big on China: $700M Innovation Hub in Qingdao 🌏💊
AstraZeneca’s $700M Qingdao investment fuels China’s rise as a global innovation leader, with a focus on breakthrough inhaled medicines. 🌍💡
AstraZeneca CEO Praises China’s Growth and Innovation 🌏💊
AstraZeneca CEO Pascal Soriot highlights China’s economic resilience and innovation leadership at Boao Forum, emphasizing supply chain strengths. 🌏💡
China Powers Up Biopharma Innovation Wave 🌊💊
China’s biopharmaceutical sector is driving global innovation and creating high-skilled jobs, says AstraZeneca’s CEO at Boao Forum 2024.
AstraZeneca Boosts China Ties with Major Investments & Innovation 🌏💊
AstraZeneca CEO discusses China’s role as a global pharma hub, highlighting investments in Wuxi and Qingdao and R&D breakthroughs. 🌍💡
Italy Tightens Restrictions as Mississippi Opens Vaccines to All 🌍💉
Italy implements new lockdown measures as Mississippi expands vaccine access to all adults. Canada maintains AstraZeneca use amid global COVID strategy shifts.